Catalog Home Page

Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss

Marsh, A.P.L., Lukic, V., Pope, K., Bromhead, C., Tankard, R.ORCID: 0000-0002-8847-9401, Ryan, M.M., Yiu, E.M., Sim, J.C.H., Delatycki, M.B., Amor, D.J., McGillivray, G., Sherr, E.H., Bahlo, M., Leventer, R.J. and Lockhart, P.J. (2015) Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss. Neurology Genetics, 1 (2). e16.

[img]
Preview
PDF - Published Version
Download (614kB) | Preview
Free to read: https://doi.org/10.1212/NXG.0000000000000014
*No subscription required

Abstract

Objective: To determine the molecular basis of a severe neurologic disorder in a large consanguineous family with complete agenesis of the corpus callosum (ACC), pontocerebellar hypoplasia (PCH), and peripheral axonal neuropathy.

Methods: Assessment included clinical evaluation, neuroimaging, and nerve conduction studies (NCSs). Linkage analysis used genotypes from 7 family members, and the exome of 3 affected siblings was sequenced. Molecular analyses used Sanger sequencing to perform segregation studies and cohort analysis and Western blot of patient-derived cells.

Results: Affected family members presented with postnatal microcephaly and profound developmental delay, with early death in 3. Neuroimaging, including a fetal MRI at 30 weeks, showed complete ACC and PCH. Clinical evaluation showed areflexia, and NCSs revealed a severe axonal neuropathy in the 2 individuals available for electrophysiologic study. A novel homozygous stopgain mutation in adenosine monophosphate deaminase 2 (AMPD2) was identified within the linkage region on chromosome 1. Molecular analyses confirmed that the mutation segregated with disease and resulted in the loss of AMPD2. Subsequent screening of a cohort of 42 unrelated individuals with related imaging phenotypes did not reveal additional AMPD2 mutations.

Conclusions: We describe a family with a novel stopgain mutation in AMPD2. We expand the phenotype recently described as PCH type 9 to include progressive postnatal microcephaly, complete ACC, and peripheral axonal neuropathy. Screening of additional individuals with related imaging phenotypes failed to identify mutations in AMPD2, suggesting that AMPD2 mutations are not a common cause of combined callosal and pontocerebellar defects.

Item Type: Journal Article
Publisher: Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Copyright: © 2015 American Academy of Neurology
URI: http://researchrepository.murdoch.edu.au/id/eprint/52054
Item Control Page Item Control Page

Downloads

Downloads per month over past year